Breakpoints cover image

#128 – IDWeek 2025 Recap

Breakpoints

00:00

PIVOT-PO: Oral Tebipenem for Complicated UTIs

Ryan summarizes the PIVOT-PO trial showing oral tebipenem noninferior to IV imipenem for complicated UTIs, including ESBL cases.

Play episode from 01:37
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app